Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Abstract
Pioglitazone is widely used for glycemic control in patients with type 2 diabetes mellitus, but evidence is mixed regarding the influence of medications of this class on cardiovascular outcomes.To systematically evaluate the effect of pioglitazone on ischemic cardiovascular events.A database containing individual patient-level time-to-event data collected during pioglitazone clinical trials was transferred from the drug's manufacturer for...
Paper Details
Title
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Published Date
Sep 12, 2007
Journal
Volume
298
Issue
10
Pages
1180 - 1180
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History